|
The balance of the RLNs at each reporting date is as follows:
|
|
|
|
|
|
|
March 31,
2024 |
|
Total liability related to the sale of future royalties, on inception |
|
$ |
10,990 |
|
Liability related to the sale of future royalties, arising from the Rights Offering |
|
|
51 |
|
Amortization of discount and debt issuance costs |
|
|
3,666 |
|
Adjustments to fair value |
|
|
(6,818 |
) |
Total liability related to the sale of future royalties at March 31, 2024 |
|
$ |
7,889 |
|
Current Portion |
|
|
— |
|
Long-term Portion |
|
$ |
7,889 |
|
|
|
|
|
|
|
December 31, 2023 |
|
Total liability related to the sale of future royalties, on inception |
|
$ |
10,990 |
|
Liability related to the sale of future royalties, arising from the Rights Offering |
|
|
51 |
|
Amortization of discount and debt issuance costs |
|
|
3,666 |
|
Adjustments to fair value |
|
|
(7,204 |
) |
Total liability related to the sale of future royalties at December 31, 2023 |
|
$ |
7,503 |
|
Current Portion |
|
|
— |
|
Long-term Portion |
|
$ |
7,503 |
|
|